We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+9.54%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$109B
AUM Growth
+$10.1B
Cap. Flow
+$2.06B
Cap. Flow %
1.89%
Top 10 Hldgs %
23.41%
Holding
4,156
New
227
Increased
1,649
Reduced
1,885
Closed
242

Sector Composition

Rank Sector Weight
1 Technology 12.51%
2 Healthcare 9.35%
3 Financials 9.21%
4 Industrials 6.82%
5 Consumer Discretionary 5.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LWLG icon
3676
Lightwave Logic
LWLG
$1.16B
$69.8K ﹤0.01%
16,188
+5,063
+46% +$36K
DNN icon
3677
Denison Mines
DNN
$3B
$69.2K ﹤0.01%
60,140
GLMD icon
3678
Galmed Pharmaceuticals
GLMD
$4.6M
$69K ﹤0.01%
767
-99
-11% -$6.48K
SLDP icon
3679
Solid Power
SLDP
$550M
$68.4K ﹤0.01%
26,921
-9,546
-26% -$40.8K
FCX icon
3680
CALL
Freeport-McMoran
FCX
$96.4B
$68.2K ﹤0.01%
96,200
+35,900
+60% +$1.25M
UWMC icon
3681
UWM Holdings
UWMC
$2.45B
$66.6K ﹤0.01%
20,124
+2,395
+14% +$8.97K
TNXP icon
3682
Tonix Pharmaceuticals
TNXP
$212M
$65.5K ﹤0.01%
+8
New +$69K
TT icon
3683
CALL
Trane Technologies
TT
$106B
$65.4K ﹤0.01%
32,700
+200
+0.6% +$33K
ETWO
3684
DELISTED
E2open Parent Holdings
ETWO
$65.4K ﹤0.01%
11,137
-963
-8% -$5.52K
BCEL
3685
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$62.1K ﹤0.01%
77,524
-6,250
-7% -$7.95K
BE icon
3686
CALL
Bloom Energy
BE
$62.2B
$61.7K ﹤0.01%
12,600
-26,400
-68% -$518K
DRRX
3687
DELISTED
DURECT Corp
DRRX
$60.4K ﹤0.01%
17,450
-4,000
-19% -$19K
BLDP
3688
Ballard Power Systems
BLDP
$784M
$59.6K ﹤0.01%
+12,445
New +$70.7K
OABI icon
3689
OmniAb
OABI
$491M
$59K ﹤0.01%
+16,382
New +$86K
SO icon
3690
CALL
Southern Company
SO
$106B
$58.5K ﹤0.01%
+32,500
New +$2.17M
TZOO icon
3691
Travelzoo
TZOO
$73.2M
$58.5K ﹤0.01%
13,140
TDAY
3692
USA Today Co
TDAY
$1B
$55.6K ﹤0.01%
27,368
+15,262
+126% +$29.3K
NVTA
3693
DELISTED
Invitae Corporation
NVTA
$55.2K ﹤0.01%
29,670
-18,359
-38% -$44.8K
GRWG icon
3694
GrowGeneration
GRWG
$89.5M
$54.6K ﹤0.01%
+13,925
New +$66.4K
IMPL
3695
DELISTED
Impel Pharmaceuticals Inc. Common Stock
IMPL
$54.4K ﹤0.01%
+14,500
New +$52.8K
OPK icon
3696
Opko Health
OPK
$1.04B
$54.1K ﹤0.01%
43,296
-22,799
-34% -$35.9K
AMRS
3697
DELISTED
Amyris Inc.
AMRS
$53.1K ﹤0.01%
34,718
-5,645
-14% -$12.6K
PPL
3698
CALL
PPL Corp
PPL
$26.5B
$52.5K ﹤0.01%
65,600
+1,400
+2% +$38.5K
JNJ icon
3699
CALL
Johnson & Johnson
JNJ
$626B
$52.4K ﹤0.01%
59,600
+11,200
+23% +$1.93M
ACIC icon
3700
American Coastal Insurance
ACIC
$464M
$52.2K ﹤0.01%
49,240
-1,200
-2% -$574

Similar funds

Raymond James & Associates's Q4 2022 Portfolio in Review

As of Q4 2022, Raymond James & Associates held 4,156 positions worth $109B, up 10% from $98.8B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Raymond James & Associates's Q4 2022 filing shows 227 new, 1,649 increased, 1,885 reduced and 242 closed positions. Its largest new stake was Rentokil: 285,133 shares worth $8.78M. The largest sale was iShares Expanded Tech Sector ETF, an estimated $79.2M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q4 2022 buy was Rentokil: 285,133 shares worth $8.78M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q4 2022, an estimated $169M increase.
  • Raymond James & Associates's biggest Q4 2022 reduction was iShares Expanded Tech Sector ETF, cutting an estimated $79.2M.
  • Raymond James & Associates fully exited Change Healthcare Inc. Common Stock in Q4 2022, selling an estimated $53.3M.
  • Raymond James & Associates's ten largest holdings make up 23% of its $109B portfolio in Q4 2022.
  • Raymond James & Associates opened 227 new positions and closed 242 in Q4 2022.
  • Raymond James & Associates's portfolio value rose 10% quarter-over-quarter to $109B.

Based on Raymond James & Associates's 13F filing for Q4 2022, filed 8 Feb 2023.